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BJPS as strategical for Pharmaceutical Sciences
QUALIS has been used by the Committee for Improvement of Higher Level Personnel (CAPES) as 
a tool for stratifying the quality of the intellectual production of Graduate Programs allover Brazil. It has 
dictating the profile of the areas of knowledge in terms of publications. Although polemic in some aspects, 
its application intends to reflect how and where the diverse areas divulge its scientific production. The criteria 
for classifying the journals depend on the area and have been periodically reviewed. 
For QUALIS 2012 version, CAPES asked the areas to choose journals considered strategic for their 
development. The journals most cited by researchers and graduate students should translate their impor‑
tance to the areas. So, BJPS, due to the high number of citations – more than 190 – during the last triennium 
(2007‑2009) of evaluation was indicated as one of the strategic journals. CAPES objective is also to support 
those nominated journals, which is expected. Strategically, its stratification should be changed to higher levels 
and based on this decision, BJPS moved from B3 to B2, independently of the Pharmacy Area indexing criteria. 
This distinction emphasizes BJPS as the main scientific vehicle for divulging the Pharmaceutical Sci‑
ences produced in the country. A higher number of manuscript submissions is thus expected. This generates 
more responsibilities and foster BJPS Scientific, Associate and Executive Editors to look forward initiatives 
toward improvement. Besides, the initial impact index attributed to BJPS by JCR 2010 should increase. 
It is worth to note that BJPS is in the process of change from an exclusively national to an international 
profile, especially after its indexing by ISI Thomas Reuters. Asian, African and Latin American scientific 
communities are increasingly submitting their manuscripts to be published in the journal. We truly value their 
collaboration and expect to reach other communities, as well. 
Starting the volume 48, we are willing to face the challenges and direct our efforts to raise BJPS to 
the top journals of Pharmaceutical Sciences. We thank the authors and editors in advance for precious col‑
laboration. 
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